OGN News and Press, Organon & Co. From 08/22/23

2023-08-22 09:23:41 ET More on 3M: 3M Company: Small Beat, Weak Guidance. Story Still All About The Liabilities 3M Company: Soaring On Earnings 3M Company: I Replaced A Loser With These Three Leaders For further details see: 3M grabs Hanson from Zimmer Bi...

VANCOUVER, BC / ACCESSWIRE / August 16, 2023 / (TSXV:OGN)(OTCQX:OGNRF) Orogen Royalties Inc. ("Orogen") or the ("Company") is pleased to provide an update on its royalty portfolio and forecast for the second half of 2023. Paddy Nicol, CEO of Orogen, commented: "Our royalty portfolio consists of...

2023-08-10 11:01:31 ET Summary Organon & Co. posted its Q2 2023 earnings on 8th August. The Merck spinouts' 3 main divisions are Women's Health, Biosimilars, and Established Brands. Total revenues were $1.6bn - up 4% ex-FX fluctuations - and diluted EPS was $0.95 - both ou...

2023-08-08 14:47:06 ET Organon ( NYSE: OGN ) stock on Tuesday was among the top percentage gainers on the S&P 500 ( SP500 ), after the women's health company reported strong Q2 results on the back of increased sales of its contraceptive Nexplanon and growth in its biosi...

2023-08-08 12:18:10 ET Organon & Co (OGN) Q2 2023 Earnings Conference Call August 08, 2023, 08:30 AM ET Company Participants Jennifer Halchak - VP, IR Kevin Ali - CEO Matthew Walsh - CFO Sandra Milligan - Head of R&D Conference Call Participants...

2023-08-08 07:34:03 ET Organon press release ( NYSE: OGN ): Q2 Non-GAAP EPS of $1.31. Revenue of $1.61B (+1.3% Y/Y). Shares +2.4% PM. Second quarter 2023 diluted earnings per share of $0.95 and non-GAAP Adjusted diluted earnings per share of $1.31 Adjusted ...

VANCOUVER, BC / ACCESSWIRE / August 8, 2023 / (TSXV:OGN)(OTCQX:OGNRF) Orogen Royalties Inc. ("Orogen") or the ("Company") is pleased to provide a drilling and resource development update on AngloGold Ashanti NA's ("AngloGold") Silicon-Merlin gold project (Figure 1) in Nevada, USA where Orogen ho...

Second quarter 2023 revenue of $1,608 million Second quarter 2023 diluted earnings per share of $0.95 and non-GAAP Adjusted diluted earnings per share of $1.31 Adjusted EBITDA of $530 million Board of Directors declares quarterly dividend of $0.28 per share Full year 2023 financia...

2023-08-06 08:01:00 ET The second week of August promises to be an eventful one for investors as a slew of major companies is set to report quarterly results. Among the headliners, Disney ( NYSE: DIS ) is prehaps the most well-known company due to report. The schedule also incl...

INCHEON, South Korea and JERSEY CITY, N.J., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Samsung Bioepis Co., Ltd. and Organon & Co. (NYSE: OGN) today announced topline results from the interchangeability study for SB5, a biosimilar to Humira ® (adalimumab). The Phase 4, randomized, double-blin...